Atlas Trials

Bial - Portela C S.A.

136 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Bial - Portela C S.A.

RecordFirmDate
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment (NCT07145190)Bial - Portela C S.A.2025-08-27
REal-life ON PARKinson's - ITaly (REONPARK-IT) (NCT07403799)Bial - Portela C S.A.2025-07-08
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs. (NCT04990284)Bial - Portela C S.A.2021-11-29
OpicApone Sleep dISorder (NCT04986995)Bial - Portela C S.A.2021-06-09
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) (NCT04978597)Bial - Portela C S.A.2021-05-31
OpiCapone Effect on Motor Fluctuations and pAiN (NCT04986982)Bial - Portela C S.A.2021-02-25
Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease (NCT03959540)Bial - Portela C S.A.2020-04-28
Safety and Efficacy of BIA 5-1058 in PAH (NCT06009185)Bial - Portela C S.A.2019-06-26
Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) (NCT04316143)Bial - Portela C S.A.2019-06-03
Anti-epileptogenic Effects of Eslicarbazepine Acetate (NCT06597084)Bial - Portela C S.A.2019-05-29
Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide (NCT07173738)Bial - Portela C S.A.2018-06-11
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058 (NCT03708146)Bial - Portela C S.A.2018-05-28
Effect of BIA 5 1058 on Cardiac Repolarization (NCT03489005)Bial - Portela C S.A.2018-04-09
Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Sildenafil (NCT04994860)Bial - Portela C S.A.2018-03-22
Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil (NCT04675944)Bial - Portela C S.A.2018-02-28
Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics (NCT04994119)Bial - Portela C S.A.2018-02-23
Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC) (NCT04265027)Bial - Portela C S.A.2018-02-20
Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan (NCT04991207)Bial - Portela C S.A.2018-02-06
Next →

Track Bial - Portela C S.A. automatically

Every clearance here is in the API, with alerts when new ones post.